EUVIMEDEUVIMED entdecken
Crossref

Individualization of frontline chronic lymphocytic leukaemia treatment – a comprehensive view on risk stratification in the era of targeted therapy

Anna Panovská

Transfuze a hematologie dnes · 15.06.2026 · 32 (2)

DOI: 10.48095/cctahd202610 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfuze a hematologie dnes, online erschienen am 15.06.2026. Verfasst von Anna Panovská.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Panovská, A. (2026). Individualization of frontline chronic lymphocytic leukaemia treatment – a comprehensive view on risk stratification in the era of targeted therapy. Transfuze a hematologie dnes, 32(2). https://doi.org/10.48095/cctahd202610

Vancouver

Panovská A. Individualization of frontline chronic lymphocytic leukaemia treatment – a comprehensive view on risk stratification in the era of targeted therapy. Transfuze a hematologie dnes. 2026;32(2). doi:10.48095/cctahd202610

BibTeX
@article{Panovsk2026,
  author = {Panovská, Anna},
  title = {Individualization of frontline chronic lymphocytic leukaemia treatment – a comprehensive view on risk stratification in the era of targeted therapy},
  journal = {Transfuze a hematologie dnes},
  year = {2026},
  volume = {32},
  number = {2},
  doi = {10.48095/cctahd202610}
}
Kostenlos starten →